{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:21:30Z","timestamp":1784560890232,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2019JJ50550"],"award-info":[{"award-number":["2019JJ50550"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2020JJ4542"],"award-info":[{"award-number":["2020JJ4542"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009020","name":"University of South China","doi-asserted-by":"publisher","award":["USCKF201902K01"],"award-info":[{"award-number":["USCKF201902K01"]}],"id":[{"id":"10.13039\/501100009020","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602443"],"award-info":[{"award-number":["81602443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81401190"],"award-info":[{"award-number":["81401190"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.heliyon.2024.e28295","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T12:49:38Z","timestamp":1710593378000},"page":"e28295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Integrated genomic and proteomic analyses identify PYGL as a novel experimental therapeutic target for clear cell renal cell carcinoma"],"prefix":"10.1016","volume":"10","author":[{"given":"Mingyong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangfeng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2334-5154","authenticated-orcid":false,"given":"Hu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.heliyon.2024.e28295_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, Mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019","volume":"8","author":"Kocarnik","year":"2022","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28295_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00000478-200203000-00001","article-title":"Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases","volume":"26","author":"Amin","year":"2002","journal-title":"Am. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28295_bib3","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/(SICI)1097-0142(19970901)80:5<987::AID-CNCR24>3.0.CO;2-R","article-title":"Classification of renal cell carcinoma: workgroup No. 1. Union internationale contre le Cancer (UICC) and the American joint committee on cancer (AJCC)","volume":"80","author":"St\u00f6rkel","year":"1997","journal-title":"Cancer"},{"issue":"9669","key":"10.1016\/j.heliyon.2024.e28295_bib4","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(09)60229-4","article-title":"Renal cell carcinoma","volume":"373","author":"Rini","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28295_bib5","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/S0022-5347(05)64153-5","article-title":"An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score","volume":"168","author":"Frank","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.heliyon.2024.e28295_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-3-319-93339-9_6","article-title":"Advances in the treatment of metastatic renal cell carcinoma","volume":"175","author":"Bergerot","year":"2018","journal-title":"Cancer Treat Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28295_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15586\/jkcvhl.2014.7","article-title":"Sunitinib resistance in renal cell carcinoma","volume":"1","author":"Morais","year":"2014","journal-title":"J Kidney Cancer VHL"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28295_bib8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nbt.3001","article-title":"The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance","volume":"32","author":"Wang","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28295_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13073-015-0208-5","article-title":"Proteogenomic analysis of psoriasis reveals discordant and concordant changes in mRNA and protein abundance","volume":"7","author":"Swindell","year":"2015","journal-title":"Genome Med."},{"key":"10.1016\/j.heliyon.2024.e28295_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108856","article-title":"Identification of survival-related predictors in hepatocellular carcinoma through integrated genomic, transcriptomic, and proteomic analyses","volume":"114","author":"Dong","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28295_bib11","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1074\/mcp.RA118.000957","article-title":"Integrated genomic and proteomic analyses reveal novel mechanisms of the methyltransferase SETD2 in renal cell carcinoma development","volume":"18","author":"Li","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28295_bib12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccell.2018.07.012","article-title":"Identification of therapeutic targets in rhabdomyosarcoma through integrated genomic, epigenomic, and proteomic analyses","volume":"34","author":"Stewart","year":"2018","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28295_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057886","article-title":"Integrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic and in the United States","volume":"8","author":"Wozniak","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28295_bib14","doi-asserted-by":"crossref","first-page":"506","DOI":"10.18632\/oncotarget.1529","article-title":"Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma","volume":"5","author":"White","year":"2014","journal-title":"Oncotarget"},{"issue":"7456","key":"10.1016\/j.heliyon.2024.e28295_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e28295_bib16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/1471-2407-12-310","article-title":"Integrative genome-wide expression profiling identifies three distinct molecular subgroups of renal cell carcinoma with different patient outcome","volume":"12","author":"Beleut","year":"2012","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28295_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cmet.2011.12.005","article-title":"Acetylation negatively regulates glycogen phosphorylase by recruiting protein phosphatase 1","volume":"15","author":"Zhang","year":"2012","journal-title":"Cell Metabol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28295_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res."},{"issue":"19","key":"10.1016\/j.heliyon.2024.e28295_bib19","doi-asserted-by":"crossref","first-page":"9498","DOI":"10.18632\/oncotarget.2411","article-title":"TOP2Ahigh is the phenotype of recurrence and metastasis whereas TOP2Aneg cells represent cancer stem cells in prostate cancer","volume":"5","author":"Li","year":"2014","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28295_bib20","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.celrep.2013.11.020","article-title":"An optimized microRNA backbone for effective single-copy RNAi","volume":"5","author":"Fellmann","year":"2013","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28295_bib21","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s12010-008-8381-2","article-title":"Polyethylenimine-based transfection method as a simple and effective way to produce recombinant lentiviral vectors","volume":"157","author":"Toledo","year":"2009","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e28295_bib22","first-page":"1942","article-title":"VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation","volume":"60","author":"Brauch","year":"2000","journal-title":"Cancer Res."},{"issue":"2 Pt 1","key":"10.1016\/j.heliyon.2024.e28295_bib23","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/01.ju.0000092861.21122.d2","article-title":"Hepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma","volume":"171","author":"Yamauchi","year":"2004","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28295_bib24","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.eururo.2015.05.045","article-title":"Survival prediction of clear cell renal cell carcinoma based on gene expression similarity to the proximal tubule of the nephron","volume":"68","author":"B\u00fcttner","year":"2015","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28295_bib25","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1186\/s12885-018-5060-8","article-title":"Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma","volume":"18","author":"Nagao","year":"2018","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28295_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2014.08.001","article-title":"Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma","volume":"33","author":"Zhou","year":"2015","journal-title":"Urol. Oncol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28295_bib27","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1097\/PAS.0b013e318299f12e","article-title":"Renal tumors: diagnostic and prognostic biomarkers","volume":"37","author":"Tan","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28295_bib28","first-page":"97","article-title":"Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from panax ginseng against MX-1 cells in vitro: experimental design and data analysis using the combination index method","volume":"6","author":"Zhang","year":"2016","journal-title":"Am. J. Cancer Res."},{"issue":"44","key":"10.1016\/j.heliyon.2024.e28295_bib29","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1038\/s41388-018-0269-1","article-title":"TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p\/vimentin signals","volume":"37","author":"Bai","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28295_bib30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12885-017-3184-x","article-title":"Functional analysis of fatty acid binding protein 7 and its effect on fatty acid of renal cell carcinoma cell lines","volume":"17","author":"Takaoka","year":"2017","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28295_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1349-7006.2006.00355.x","article-title":"Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma","volume":"98","author":"Domoto","year":"2007","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28295_bib32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/1440-1681.13220","article-title":"Knockdown of TMEM45A overcomes multidrug resistance and epithelial-mesenchymal transition in human colorectal cancer cells through inhibition of TGF-\u03b2 signalling pathway","volume":"47","author":"Zhu","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28295_bib33","first-page":"12657","article-title":"Knockdown of TMEM45A inhibits the proliferation, migration and invasion of glioma cells","volume":"8","author":"Sun","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28295_bib34","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.3892\/or.2015.3902","article-title":"Inhibition of TMEM45A suppresses proliferation, induces cell cycle arrest and reduces cell invasion in human ovarian cancer cells","volume":"33","author":"Guo","year":"2015","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28295_bib35","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.eururo.2015.08.007","article-title":"Hypoxia, hypoxia-inducible transcription factors, and renal cancer","volume":"69","author":"Sch\u00f6del","year":"2016","journal-title":"Eur. Urol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28295_bib36","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/PAI.0000000000000012","article-title":"Constitutive expression of HIF-\u03b1 plays a major role in generation of clear-cell phenotype in human primary and metastatic renal carcinoma","volume":"22","author":"T\u00f3th","year":"2014","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28295_bib37","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1080\/15384101.2021.2020431","article-title":"Nc886 promotes renal cancer cell drug-resistance by enhancing EMT through Rock2 phosphorylation-mediated \u03b2-catenin nuclear translocation","volume":"21","author":"Gao","year":"2022","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28295_bib38","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41374-019-0188-y","article-title":"Epithelial-mesenchymal transition as a mechanism of resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma","volume":"99","author":"Hwang","year":"2019","journal-title":"Lab. Invest."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024043263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024043263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:23:06Z","timestamp":1782246186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024043263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2405844024043263"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28295","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated genomic and proteomic analyses identify PYGL as a novel experimental therapeutic target for clear cell renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e28295"}}